GGrantIndex
← Leaderboards

Stuart C Ray

Johns Hopkins University

$7,743,036
Attributed
$8,508,481
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $808.9K · FY200522
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$8,508,481 · 7

By mechanism

R01$4,876,784 · 3
U19$3,304,697 · 3
R21$327,000 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Hepatitis C Virus

Research focus

Hepatitis C VirusInfectionHepatitis CInvestigationViralEpitopesResponseLongitudinal StudiesImmune ResponsePersonsAcuteBaseT-LymphocyteVariantIn VivoCd8b1 GeneEvolutionAnti-Hepatitis CFitnessGenomeAcute Hepatitis CCohortCd4 Positive T LymphocytesViral Proteins

Grant awards (29)

SCH: A Computer Vision and Lens-Free Imaging System for Automatic Monitoring of Infections$274,621
R01 · FY2022 · AG
SCH: A Computer Vision and Lens-Free Imaging System for Automatic Monitoring of Infections$283,097
R01 · FY2021 · AG
SCH: A Computer Vision and Lens-Free Imaging System for Automatic Monitoring of Infections$291,252
R01 · FY2020 · AG
Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans$175,232
U19 · FY2020 · AI · contact PI
SCH: A Computer Vision and Lens-Free Imaging System for Automatic Monitoring of Infections$299,197
R01 · FY2019 · AG
Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans$277,606
U19 · FY2019 · AI · contact PI
Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans$183,109
U19 · FY2018 · AI · contact PI
Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans$122,281
U19 · FY2016 · AI · contact PI
Humoral Immune Response to Acute HCV Infection$270,712
U19 · FY2014 · AI · contact PI
Humoral Immune Response to Acute HCV Infection$302,632
U19 · FY2013 · AI · contact PI
Humoral Immune Response to Acute HCV Infection$250,405
U19 · FY2012 · AI · contact PI
Mechanisms of Hepatitis C Virus Evolution$527,079
R01 · FY2011 · DA · contact PI
Humoral Immune Response to Acute HCV Infection$221,762
U19 · FY2011 · AI · contact PI
Mechanisms of Hepatitis C Virus Evolution$527,839
R01 · FY2010 · DA · contact PI
Humoral Immune Response to Acute HCV Infection$215,768
U19 · FY2010 · AI · contact PI
Mechanisms of Hepatitis C Virus Evolution$517,928
R01 · FY2009 · DA · contact PI
Cellular Immune Failure in Acute Hepatitis C$290,931
U19 · FY2009 · AI · contact PI
Mechanisms of Hepatitis C Virus Evolution$503,137
R01 · FY2008 · DA · contact PI
Cellular Immune Failure in Acute Hepatitis C$282,921
U19 · FY2008 · AI · contact PI
Mechanisms of Hepatitis C Virus Evolution$517,865
R01 · FY2007 · DA · contact PI
Cellular Immune Failure in Acute Hepatitis C$244,339
U19 · FY2007 · AI · contact PI
Cellular Immune Failure in Acute Hepatitis C$238,929
U19 · FY2006 · AI · contact PI
Cellular Immune Failure in Acute Hepatitis C$228,070
U19 · FY2005 · AI
Hepatitis C Recombination Incidence and Prevalence$163,500
R21 · FY2004 · DA
SEQUENCE SELECTION AND PERSISTENCE OF HEPATITIS C$343,379
R01 · FY2003 · DK
Hepatitis C Recombination Incidence and Prevalence$163,500
R21 · FY2003 · DA
SEQUENCE SELECTION AND PERSISTENCE OF HEPATITIS C$333,398
R01 · FY2002 · DK
SEQUENCE SELECTION AND PERSISTENCE OF HEPATITIS C$233,503
R01 · FY2001 · DK
SEQUENCE SELECTION AND PERSISTENCE OF HEPATITIS C$224,489
R01 · FY2000 · DK